1st results in on Gilead coronavirus drug; more study needed

More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug, although there’s no way to know the odds of that happening without the drug because there was no comparison group, doctors reported Friday.The resultspublished by the New England Journal of Medicine are the first in COVID-19 patients for remdesivir.The Gilead Sciences drug has shown promise against other coronaviruses in the past and in lab tests against the one causing t